» Articles » PMID: 9399644

Cdk2-dependent Phosphorylation of P27 Facilitates Its Myc-induced Release from Cyclin E/cdk2 Complexes

Overview
Journal Oncogene
Date 1997 Dec 17
PMID 9399644
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of Myc triggers a rapid induction of cyclin E/cdk2 kinase activity and degradation of p27. Overt degradation of p27 is preceded by a specific dissociation of p27 from cyclin E/cdk2, but not from cyclin D/cdk4 complexes. We now show that cyclin E/cdk2 phosphorylates p27 at a carboxy-terminal threonine residue (T187) in vitro; mutation of this residue to valine stabilises cyclin E/cdk2 complexes. This reaction is not significantly inhibited by high concentrations of p27, suggesting that cdk2 bound to p27 is catalytically active. In vivo, p27 bound to cyclins E and A, but not to D-type cyclins is phosphorylated. Myc-induced release of p27 from cdk2 requires cdk2 kinase activity and is delayed in a T187V mutant of p27. After induction of Myc, p27 phosphorylated at threonine 187 transiently accumulates in a non cdk2 bound form. Our data suggest a mechanism in which p27 is released from cyclin E/cdk2 upon phosphorylation; in Myc-transformed cells, release is efficient as phosphorylated p27 is transiently bound in a non-cdk2 containing complex and subsequently degraded.

Citing Articles

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Ahmadi S, Rahimi S, Zarandi B, Chegeni R, Safa M J Hematol Oncol. 2021; 14(1):121.

PMID: 34372899 PMC: 8351444. DOI: 10.1186/s13045-021-01111-4.


Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.

Garcia-Gutierrez L, Bretones G, Molina E, Arechaga I, Symonds C, Acosta J Sci Rep. 2019; 9(1):18693.

PMID: 31822694 PMC: 6904551. DOI: 10.1038/s41598-019-54917-1.


Structural basis for the ORC1-Cyclin A association.

Wang B, Song J Protein Sci. 2019; 28(9):1727-1733.

PMID: 31309634 PMC: 6699096. DOI: 10.1002/pro.3689.


MYC Oncogene Contributions to Release of Cell Cycle Brakes.

Garcia-Gutierrez L, Delgado M, Leon J Genes (Basel). 2019; 10(3).

PMID: 30909496 PMC: 6470592. DOI: 10.3390/genes10030244.


Upregulation of cyclin-dependent kinase inhibitors CDKN1B and CDKN1C in hepatocellular carcinoma-derived cells via goniothalamin-mediated protein stabilization and epigenetic modifications.

Peng Y, Wu W, Chen L, Kuo K, Tsai C, Huang Y Toxicol Rep. 2017; 2:322-332.

PMID: 28962365 PMC: 5598353. DOI: 10.1016/j.toxrep.2015.01.010.